Search details
1.
Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
Dig Dis Sci
; 66(3): 881-898, 2021 03.
Article
in English
| MEDLINE | ID: mdl-32303953
2.
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial.
J Hepatol
; 72(3): 431-440, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31655134
3.
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet
; 393(10179): 1453-1464, 2019 Apr 06.
Article
in English
| MEDLINE | ID: mdl-30765123
4.
Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r.
Hepatology
; 69(2): 513-523, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30125371
5.
Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy.
Liver Int
; 40(1): 74-82, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31444947
6.
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study.
Liver Int
; 40(5): 1042-1051, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31765046
7.
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
Clin Gastroenterol Hepatol
; 17(3): 518-526, 2019 02.
Article
in English
| MEDLINE | ID: mdl-29857143
8.
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure.
Hepatology
; 67(4): 1253-1260, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29152781
9.
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.
BMC Infect Dis
; 19(1): 300, 2019 Apr 02.
Article
in English
| MEDLINE | ID: mdl-30940090
10.
Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage.
J Infect Dis
; 217(3): 474-482, 2018 01 17.
Article
in English
| MEDLINE | ID: mdl-29228392
11.
Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.
Clin Infect Dis
; 66(7): 1013-1018, 2018 03 19.
Article
in English
| MEDLINE | ID: mdl-29077864
12.
Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies.
J Hepatol
; 68(5): 895-903, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29221887
13.
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis.
J Hepatol
; 69(2): 293-300, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29551706
14.
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
N Engl J Med
; 373(27): 2599-607, 2015 Dec 31.
Article
in English
| MEDLINE | ID: mdl-26571066
15.
Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis.
Gastroenterology
; 152(6): 1372-1382.e2, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28193518
16.
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
Gastroenterology
; 153(1): 49-52.e5, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28288791
17.
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis.
Clin Gastroenterol Hepatol
; 16(3): 417-426, 2018 03.
Article
in English
| MEDLINE | ID: mdl-28951228
18.
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study.
Hepatology
; 66(3): 736-745, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28256747
19.
Treatment of hepatitis C: Results in real life.
Liver Int
; 38 Suppl 1: 21-27, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-29427481
20.
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes.
Value Health
; 21(10): 1218-1225, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30314623